31 July 2020: Articles
Early Pulmonary Metastasis After a Surgical Resection of Glioblastoma Multiforme. A Case Report
Diagnostic / therapeutic accidents
Killen H. Briones-Claudett123ABCDEFG*, Mónica H. Briones-Claudett23ABDEF, Freddy Villacrés Garcia3ABDE, Camilo Ortega Almeida3ABCD, Andrea Escudero-Requena3ABCD, Jaime Benítez Solís4DEFG, Killen H. Briones Zamora5DEFG, Diana C. Briones Márquez1DEFG, Michelle Grunauer67CDEFGDOI: 10.12659/AJCR.922976
Am J Case Rep 2020; 21:e922976
Abstract
BACKGROUND: Glioblastoma multiforme is one of the most aggressive types of tumors that affect the central nervous system. It has an extremely high morbidity and mortality rate despite immediate treatment and advances in chemotherapy, radiotherapy, and surgery. In the natural history of the disease, extracranial metastases of glioblastoma multiforme are a rare complication that can be localized in the lungs, bone, liver, and lymph nodes.
CASE REPORT: A 66-year-old male presented with pulmonary metastasis after the surgical resection of a primary glioblastoma multiforme tumor. Seventeen days after surgery while in the intensive care unit, the patient had leukocytosis with a predominance of neutrophils. An exploratory bronchoscopy evidenced a white lesion that prevented the visualization of the bronchus. Consequently, a sample was taken for pathological study that demonstrated pulmonary metastasis due to glioblastoma multiforme.
CONCLUSIONS: Surgical resection of the tumor can precipitate the appearance of extracranial metastases, especially pulmonary metastases.
Keywords: Glioma, Biopsy, Fatal Outcome
Background
Pulmonary metastases are extracranial manifestations that infrequently occur as a consequence of a glioblastoma multiforme (GBM). There is usually no invasion of blood vessels and, in rare cases, it spreads outside the central nervous system (CNS) [1]. Epidemiologically, younger patients are more susceptible to developing extracranial metastases, occurring in approximately 0.2% to 1% of cases [2]. The most common site of extracranial metastasis of GBM is the lung, although it may also spread to the liver, bone, or lymph nodes [3].
GBM is the most common and aggressive primary neoplasm that occurs in the brain. Its prognosis as a malignant tumor is discouraging due to its high rate of recurrence despite surgical resection, chemotherapy, and radiation. It should be emphasized that GBM resection is not usually complete due to the behavior of the tumor, which has an infiltrative growth pattern [4].
The literature reports cases of precipitation of postoperative metastases in patients mainly with GBM, but these metastases have been reported 4 to 6 months after surgical resection and treatment with radiotherapy or chemotherapy [5].
We report the case of a 66-year-old male patient who, 17 days after the resection of a right parietal GBM, had histopatho-logical-proven pulmonary nodules consistent with pulmonary metastases of GBM.
Case Report
POSTOPERATIVE EVALUATION:
Immediately after the procedure, the patient was transferred to the Intensive Care Unit (ICU) for monitoring. On the first postoperative day, the patient received invasive mechanical ventilation (IMV) in IPPV mode. Ampicillin+sulbactam antibiotic scheme was established at 3 g every 6 hours+dexamethasone 8 mg intravenous (IV) every 6 hours. Leukocytosis with a predominance of neutrophils was reported and blood, urine, and bronchial secretion samples were taken, evidencing no bacterial growth 48 to 72 hours later. The patient was extubated to 48 hours post-operative.
On the fifth postoperative day, a standard chest x-ray was performed, which reported findings within normal parameters. On the seventh day of hospitalization in the ICU, moderate hyponatremia was detected and was corrected with hypertonic saline. A brain computed tomography (CT) scan was obtained and revealed a hypodense image in the peripheral zone.
On the 15th day in the ICU, a chest x-ray revealed a diffuse alveolar infiltrate of left lung base without evidence of pleural effusion or masses. On the 17th day in the ICU, the patient presented new leukocytosis with predominantly neutrophils. Antibiotics were changed to IV cefepime 2 gr every 8 hours. An exploratory bronchoscopy revealed the presence of thickening of the mucosa and areas consistent with anthracosis protrusion area partially obstructing the bronchial lumen (Figure 3A).
A sample was taken for microbiological and pathological study. Images of chest-x ray and CT scan were evidenced 19 days later in which a unique nodular image is observed (Figure 1B, 1C).
The patient continued to deteriorate, sustained poor respiratory mechanics, and became hemodynamically unstable. The patient experienced cardiorespiratory arrest and after advanced cardio-pulmonary resuscitation (CPR) was performed, he passed away.
PATHOLOGY OF THE BRAIN LESION:
A fragment of grayish brown tissue measuring 2.5×2.2 cm, friable, and with areas of hemorrhage was sent for biopsy. The histological sections revealed densely cellular neoplasia consisting of polygonal ovoid round cells and fusiform with signs of anaplasia evidenced by macronucleosis, hyperchromatism, pleomorphism, and intense mitotic activity (>25×10) with alteration of the polarity and the nucleus-cytoplasm relationship.
There were areas of necrosis surrounded by viable tumor cell palisades, as well as proliferation of glomeruloid vessels of swollen endothelium, typical of high-grade gliomas (Figure 4).
BIOPSY OF LUNG TISSUE:
Minute fragments of tissue were observed consisting of a dense cellularity of round, ovoid and elongated elements, with signs of anaplasia evidenced by macronucleosis, nucleolar prominence, altered polarity and nucleo-cytoplasm relationship possibly corresponding to metastatic spread of brain neoplasia (Figure 3B).
Discussion
Extracranial metastases of GBM are rare, with a reported incidence of less than 2% [6]. In most documented cases, these patients have undergone a resection by means of open craniotomy, which suggests the hypothesis of iatrogenic exposure of tumor cells through blood vessels. Due to the rarity of this condition, it is not clear if overall survival in GBM is diminished in the context of extracranial GBM metastasis [1].
The preoperative assessment of the extent of the lesion, as well as certain preoperative inflammatory markers, have recently been highlighted for their important value in the prognosis and survival of patients.
Our patient underwent a GBM resection and developed pulmonary nodules identified as extracranial GBM metastasis in the lung. The mechanism of dissemination is not clear, however, as mentioned in the literature, post-surgical iatrogenic sowing is suggested [6].
Extracranial metastases are usually rare due mainly to 1) the absence of lymphatic vessels in the CNS, 2) the absence of communication between the peri-vascular and extracranial spaces, 3) the fact that intracranial veins are thin-walled, and 4) the fact that meningeal tumors grow in the dura mater and remain only on the surface. The dural veins are protected by a dense connective tissue. Therefore, for the tumor to metastasize, it must follow different routes. These routes are mainly hematogenous, either by invasion of the primary or lymphatic tumor after the infiltration of the skull or to the extracranial soft tissue, which can be precipitated by the surgical intervention [7].
Craniotomy alters the mechanism of innate defense of the CNS and facilitates tumor cells entering the blood vessels hematogenously, which is the main route for the metastasis of other solid organs (lung, bone, and spleen) [8]. The lungs are the first filter for the tumor cells. Tumor cells that are mechanically trapped in the lung, might result in lung metastasis [9].
Among the limitations found for the diagnosis and correct evaluation of this patient, some histochemical characteristics of the tumor were not analyzed. Furthermore, some studies have linked subclones [10] that are genetically altered in the primary tumor to the presence of extracranial metastases. However, advanced age and postoperative infections have been related to survival [11].
The preoperative assessment of the extent of the lesion, as well as certain preoperative inflammatory markers, have recently been highlighted for their important value in the prognosis and survival of patients [12].
Conclusions
In this clinical case study, the rapid presentation of pulmonary metastasis was the main clinical presentation that was related to surgical resection. Although pulmonary metastases are rare events and the mechanisms through which they develop are not fully defined, clinicians must take this clinical possibility into account post-brain-tumor resection to achieve adequate and effective diagnostic management and thus improve the quality of life of our patients.
Figures
References:
1.. Piccirilli M, Brunetto GM, Rocchi G, Extra central nervous system metastases from cerebral glioblastoma multiforme in elderly patients. Clinico-pathological remarks on our series of seven cases and critical review of the literature: Tumori, 2008; 94(1); 40-51
2.. Tatter SB, Wilson CB, Harsh GR, Neuroepithelial tumors of the adult brain: Neurological Surgery, 1995 Chapter 121
3.. Ueda S, Mineta T, Suzuyama K, Biologic characterization of a secondary glioblastoma with extracranial progression and systemic metastasis: Neuro Oncol, 2003; 5(1); 14-18
4.. Lun M, Lok E, Gautam S, Wu E, Wong ET, The natural history of extracrania metastasis from glioblastoma multiforme: J Neurooncol, 2011; 105(2); 261-73
5.. Wu W, Zhong D, Zhao Z, Postoperative extracranial metastasis from glioblastoma: A case report and review of the literature: World J Surg Oncol, 2017; 15(1); 231
6.. Werner MH, Phuphanich S, Lyman GH, The increasing incidence of malignant m gliomas and primary central nervous system lymphoma in the elderly: Cancer, 1995; 76(9); 1634-42
7.. Hamilton JD, Rapp M, Schneiderhan T, Sabel M, Glioblastoma multi-forme metastasis outside the CNS: Three case reports and possible mechanisms of escape: J Clin Oncol, 2014; 32(22); e80-84
8.. Frank S, Kuhn SA, Brodhun M, Metastatic glioblastoma cells use common pathways via blood and lymphatic vessels: Neurol Neurochir Pol, 2009; 43(2); 183-90
9.. Polley MY, Lamborn KR, Chang SM, Conditional probability of survival in patients with newly diagnosed glioblastoma: J Clin Oncol, 2011; 29(31); 4175-80
10.. Park CC, Hartmann C, Folkerth R, Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones: J Neuropathol Exp Neurol, 2000; 59(12); 1044-50
11.. De Bonis P, Albanese A, Lofrese G, Postoperative infection may influence survival in patients with glioblastoma: Simply a myth?: Neurosurgery, 2011; 69(4); 864-68
12.. Pierscianek D, Ahmadipour Y, Michel A, Prediction of preoperative survival in patients with glioblastoma by routine inflammatory laboratory parameters: Anticancer Res, 2020; 40(2); 1161-66
Figures
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946215
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946869
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947011
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946427
Most Viewed Current Articles
21 Jun 2024 : Case report
94,176
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
51,416
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
28,562
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,092
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030